CitoxLAB cites LAB takeover as driver and hints at collaboration with clinical CROs
CiToxLAB says LAB Research acquisition was key driver for growth in H1 2012 and hints at future collaborations with clinical CROs.
CiToxLAB says LAB Research acquisition was key driver for growth in H1 2012 and hints at future collaborations with clinical CROs.
Almac has invested in new flexible blister tech for its site in Northern Ireland facility just months after bolstering its US packaging business.
Icon has forged an alliance with the South Korean Government in a bid to boost local trial activity.
EXCLUSIVE
Latest EMA biosimilar guidance on reference products is a “major breakthrough” but there is still work to do, say industry experts.
A US Bill designed to stop price gouging during drug shortages has progressed to the Committee stage.